Medpace CEO August J. Troendle sells USD 30.02 million in common shares
MEDP•Medpace CEO August J. Troendle sold 48,667 common shares for USD 30.02 million on Sept. 29-30.
MEDP•MEDP•MEDP•Medpace CEO August J. Troendle sold 48,667 common shares for USD 30.02 million on Sept. 29-30.
Troendle sold 48,667 shares at USD 621.02 per share on Sept. 29 and USD 625.47 per share on Sept. 30. His directly held stake fell to 338,225 shares; he also reported 4,733,019 shares held indirectly through Medpace Investors.
